Kang et al. found that inhibition of PLD1 suppresses the PI3K–mTOR pathway and results in reduced cell proliferation, migration, and invasion in vitro, as well as reduced tumour growth and EMT of patient-derived xenografts in colorectal and hepatocellular carcinoma [175,178]. The gene discussed is PLD1; the disease is hepatocellular carcinoma.